Walleye Capital’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $927K | Sell |
183,930
-67,036
| -27% | -$338K | ﹤0.01% | 865 |
|
2025
Q1 | $1.63M | Sell |
250,966
-183,494
| -42% | -$1.19M | 0.01% | 666 |
|
2024
Q4 | $3.19M | Buy |
434,460
+410,684
| +1,727% | +$3.01M | 0.01% | 558 |
|
2024
Q3 | $178K | Buy |
+23,776
| New | +$178K | ﹤0.01% | 1735 |
|
2024
Q2 | – | Sell |
-172,656
| Closed | -$1.75M | – | 2991 |
|
2024
Q1 | $1.75M | Sell |
172,656
-11,168
| -6% | -$113K | ﹤0.01% | 818 |
|
2023
Q4 | $1.85M | Sell |
183,824
-394,711
| -68% | -$3.97M | ﹤0.01% | 670 |
|
2023
Q3 | $5.42M | Sell |
578,535
-284,845
| -33% | -$2.67M | 0.01% | 364 |
|
2023
Q2 | $21.2M | Buy |
+863,380
| New | +$21.2M | 0.08% | 44 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 2758 |
|
2022
Q1 | – | Sell |
-5,100
| Closed | -$214K | – | 2552 |
|
2021
Q4 | $214K | Buy |
+5,100
| New | +$214K | 0.01% | 1394 |
|